Navigation Links
Array BioPharma Announces Clinical Data Presentations At The 2013 ASCO Annual Meeting
Date:5/15/2013

results of selumetinib versus temozolomide in uveal melanoma (Abstract # CRA9003) will lift on Saturday, June 1 at 6:30 a.m. CDT.  ASCO's embargo for the remaining abstracts in this release will lift on Wednesday, May 15 at 6:00 p.m. EDT.  All abstracts can be accessed through the ASCO website, http://abstract.asco.org/.  After the presentations and posters are public, they will be available as PDFs on Array's website at www.arraybiopharma.com.

*The MEK162 abstract submitted only incorporates data as of early 2013.  Up-to-date clinical data will be included during the presentation at the Annual Meeting.

About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Array is evolving into a late-stage development company and currently expects significant progress toward generating data to support our upcoming Phase 3 / pivotal trial decisions.
Novartis expects to begin Phase 3 trials evaluating Array-invented MEK162 in NRAS- and BRAF-mutant melanoma in 2013.  In addition, Array expects to begin a Phase 3 trial evaluating MEK162 in low-grade serous ovarian cancer under the license agreement with Novartis in 2013.  AstraZeneca expects to begin Phase 3 or pivotal registration trials with selumetinib (an Array-invented drug) in non-small cell lung cancer and thyroid cancer during the second half of 2013.  Three other Array-invented drugs are also approaching Phase 3 or pivotal trial decisions which are expected by the end of 2013. These include Array's wholly-owned drugs, ARRY-520 and ARRY-614, and one partnered program, danoprevir (with InterMune/Roche).  For more information on Array, please go to www.arraybiopharma.com.

(Logo: 
'/>"/>

SOURCE Array BioPharma Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Array Announces Global Phase 3 Trial Evaluating MEK162 In Patients With Low-Grade Serous Ovarian Cancer
2. Array BioPharma Reports Financial Results for the Third Quarter of Fiscal 2013
3. New Versa HD System Tops Elektas Comprehensive Array of Cancer Management Solutions at 2nd ESTRO Forum
4. Array BioPharma Announces Updates on ARRY-520 Clinical Data at the 2013 International Myeloma Workshop
5. Array BioPharma Names Michael N. Needle, M.D. As Chief Medical Officer
6. Array BioPharma To Present At The Cowen Annual Health Care Conference
7. Zacks Bull and Bear of the Day Highlights: Fortune Brands Home & Security, Wal-Mart Stores, Regeneron Pharmaceuticals, Bayer and Array Biopharma
8. Array BioPharma To Present At The Leerink Swann Global Healthcare Conference
9. InternetArray Collaborates with Health Sciences Group to Fund Medical Marijuana Social Media/Mobile Apps Development
10. Array BioPharma To Present At The Piper Jaffray Annual Healthcare Conference
11. Array BioPharma Announces Pricing Of Public Offering Of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/4/2015)... July 4, 2015 Añadir ... quimioterapia de primera línea para pacientes con cáncer ... extiende la supervivencia libre de progresión en ese ... metastásico no resecable (mCRC) que se ha propagado ... la supervivencia libre de progresión (PFS) en el ...
(Date:7/4/2015)... 4, 2015 De ... chemotherapie voor patiënten met niet-resectabele uitgezaaide colorectale ... progressievrije overleving in dat orgaan. ... (mCRC) die alleen binnen de lever is ... overleving (PFS) in de lever dankzij de ...
(Date:7/4/2015)... , July 4, 2015 ... for patients with unresectable metastatic colorectal cancer in ... that organ Patients with unresectable metastatic ... the liver experienced the greatest improvement in Progression-Free ... of SIR-Spheres Y-90 resin microspheres to a current ...
Breaking Medicine Technology:El Congreso Mundial del Cáncer Gastrointestinal presenta nuevos datos del estudio SIRFLOX 2El Congreso Mundial del Cáncer Gastrointestinal presenta nuevos datos del estudio SIRFLOX 3El Congreso Mundial del Cáncer Gastrointestinal presenta nuevos datos del estudio SIRFLOX 4El Congreso Mundial del Cáncer Gastrointestinal presenta nuevos datos del estudio SIRFLOX 5Nieuwe SIRFLOX onderzoeksgegevens gepresenteerd op World Congress of Gastrointestinal Cancer 2Nieuwe SIRFLOX onderzoeksgegevens gepresenteerd op World Congress of Gastrointestinal Cancer 3Nieuwe SIRFLOX onderzoeksgegevens gepresenteerd op World Congress of Gastrointestinal Cancer 4Nieuwe SIRFLOX onderzoeksgegevens gepresenteerd op World Congress of Gastrointestinal Cancer 5New SIRFLOX Study Data Presented at World Congress of Gastrointestinal Cancer 2New SIRFLOX Study Data Presented at World Congress of Gastrointestinal Cancer 3New SIRFLOX Study Data Presented at World Congress of Gastrointestinal Cancer 4
... , LOS ANGELES , June 1 One minute ... their two dogs. The next, they had shattered legs and pelvises and one of ... horrifying impact, leaving them to put the pieces of their lives back together. ... In the nearly two years since ...
... CareFusion (NYSE: CFN ), a leading, ... Closed Loop Controller of Inspired Oxygen system or "CLiO2™," the ... the oxygen level in the blood within a safe range ... an enhancement to the CareFusion AVEA™ ventilator, one of the ...
Cached Medicine Technology:The SCOOTER Store Donates Scooter to Hit-and-Run Accident Victim 2The SCOOTER Store Donates Scooter to Hit-and-Run Accident Victim 3CareFusion Launches First Automatic Oxygen Controller to Improve Care for Newborns Needing Mechanical Ventilation 2CareFusion Launches First Automatic Oxygen Controller to Improve Care for Newborns Needing Mechanical Ventilation 3
(Date:7/3/2015)... Greenville, SC (PRWEB) , ... ... ... Society has announced the sessions and speaker lineup for its 2015 ... nursing, taking place August 6-8, 2015 at the Renaissance Orlando at SeaWorld ...
(Date:7/3/2015)... ... July 03, 2015 , ... ... healthcare providers, has been retained to lead a national chief nursing officer ... top-ranked executive search firms in the healthcare industry, B. E. Smith has recently ...
(Date:7/3/2015)... ... ... Jennifer Renee Hanes, DO is the new Medical Director of its Sienna Plantation ... emergency rooms in the United States. , “We are excited to welcome Dr. Hanes ... Director of First Choice Emergency Room, Dr. James M. Muzzarelli. , Dr. Hanes ...
(Date:7/3/2015)... ... July 03, 2015 , ... Every year, One-to-1 Fitness ... where they provide members of the Red Deer community with free fitness training and ... fitness training, games, food, events and entertainment raised thousands of charity dollars and ended ...
(Date:7/2/2015)... ... July 02, 2015 , ... sweetFrog Enterprises, LLC. is pleased to ... the 19th sweetFrog store located in the Lone Star State. The premium frozen yogurt ... in 2014. , The store, which opened July 1 at Duke’s Travel Plaza, is ...
Breaking Medicine News(10 mins):Health News:RNS Announces Sessions and Speaker Lineup for the 2015 Annual Conference of the Rheumatology Nurses Society 2Health News:RNS Announces Sessions and Speaker Lineup for the 2015 Annual Conference of the Rheumatology Nurses Society 3Health News:Jane Phillips Medical Center Retains B. E. Smith to Recruit New Chief Nursing Officer 2Health News:Jane Phillips Medical Center Retains B. E. Smith to Recruit New Chief Nursing Officer 3Health News:Dr. Jennifer Renee Hanes Named by First Choice Emergency Room as Medical Director of Missouri City, TX Facility 2Health News:Dr. Jennifer Renee Hanes Named by First Choice Emergency Room as Medical Director of Missouri City, TX Facility 3Health News:Red Deer Fitness Studio Raises $10,000 for Charity Organization with 24-Hour Train-a-Thon 2Health News:Red Deer Fitness Studio Raises $10,000 for Charity Organization with 24-Hour Train-a-Thon 3Health News:sweetFrog Expands Texas Footprint with Location in Canton 2
... your own back, have a loved one take a look, study ... delivers a lifesaving message to older men about the potentially deadly ... back, have a loved one take a look, and if there,s ... why it is that when a doctor finds a melanoma, it ...
... Nicole Lauzon and Dr. Steven Laviolette of the Schulich ... Western Ontario has found key processes in the brain ... how we form memories of them. A lack of ... beneath such conditions as Schizophrenia and Post-Traumatic Stress Disorder ...
... Mark Leventhal, Esq., the Founder and President of Leventhal Consulting, ... executive weight loss consulting service for attorneys by an attorney, ... 1055 West 7th Street, 27th Floor, today. His presentation ... Mark Leventhal will be talking about the importance of losing ...
... Presented at the 2009 Experimental Biology ConferenceOMAHA, Neb., April ... shows people who ate Healthy Choice(R) really did get ... 18 pounds - all as fat - trimmed their ... by 12 points. Leading cardiologist Dr. James Rippe, founder ...
... Connectivity with Clearinghouses, Strategic Trading Partners and Bill ... CONCORD, Calif., April 20 Jopari Solutions, ... EDI Gateway services, is further expanding its connectivity ... enables Jopari to position mission critical eBill connectivity ...
... The search for the cause of an inherited form ... important information about how the cancer develops and potentially ... , The finding by researchers at Washington University School ... in Washington, D.C., the International Pleuropulmonary Blastoma Registry at ...
Cached Medicine News:Health News:Older Men Need to Take Closer Look for Melanomas 2Health News:Older Men Need to Take Closer Look for Melanomas 3Health News:Controlling our brain's perception of emotional events 2Health News:Mark Leventhal Speaks at the Los Angeles County Bar Association 2Health News:New Research Shows Healthy Choice Lives Up To Its Name 2Health News:New Research Shows Healthy Choice Lives Up To Its Name 3Health News:Jopari Further Expands Nationwide Medical Billing Network Connectivity for Workers' Comp and Auto Providers and Payers 2Health News:Jopari Further Expands Nationwide Medical Billing Network Connectivity for Workers' Comp and Auto Providers and Payers 3Health News:Genetic source of rare childhood cancer found; gene is implicated in other cancers 2Health News:Genetic source of rare childhood cancer found; gene is implicated in other cancers 3
... family of infrared laser photocoagulators includes the ... diode lasers serve as a single laser ... require no regular maintenance or special electrical/cooling, ... design. The OcuLight SLx is now available ...
... is the least expensive of the series. It has ... central area of the cornea. The model comes with ... a picture of a patients corneal endothelium, you simply ... on the chin rest. The left side of the ...
... permeable contact lenses used for corneal refractive ... (myopia). The patient wears the lenses overnight ... During the day, nearsightedness is corrected or ... RG contact lenses apply slight pressure to ...
... the major challenges to operating your ... market fee for each procedure includes:, ... requirements., Board Certified Nuclear Medicine Technologist., ... Hot Lab Equipment and Accessories., All ...
Medicine Products: